Equities analysts expect that Valeritas Holdings, Inc. (NASDAQ:VLRX) will announce sales of $5.14 million for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Valeritas Holdings’ earnings. The lowest sales estimate is $5.00 million and the highest is $5.29 million. Valeritas Holdings reported sales of $4.89 million in the same quarter last year, which indicates a positive year over year growth rate of 5.1%. The business is scheduled to issue its next earnings report on Wednesday, August 9th.
According to Zacks, analysts expect that Valeritas Holdings will report full year sales of $5.14 million for the current fiscal year, with estimates ranging from $21.84 million to $22.43 million. For the next financial year, analysts expect that the firm will post sales of $28.04 million per share, with estimates ranging from $26.03 million to $30.00 million. Zacks’ sales averages are a mean average based on a survey of research firms that that provide coverage for Valeritas Holdings.
Valeritas Holdings (NASDAQ:VLRX) last released its earnings results on Friday, May 12th. The company reported ($6.92) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($2.72) by $4.20. The business had revenue of $4.61 million for the quarter, compared to analyst estimates of $4.64 million.
Several analysts have recently commented on the stock. B. Riley reiterated a “buy” rating and issued a $10.00 price target on shares of Valeritas Holdings in a research report on Tuesday, April 4th. Cowen and Company assumed coverage on shares of Valeritas Holdings in a research note on Monday, April 17th. They set an “outperform” rating on the stock. Finally, ValuEngine downgraded shares of Valeritas Holdings from a “sell” rating to a “strong sell” rating in a research note on Thursday, May 11th.
In other news, major shareholder Capital Royalty L.P. acquired 4,000,000 shares of Valeritas Holdings stock in a transaction that occurred on Tuesday, March 28th. The shares were acquired at an average price of $10.00 per share, with a total value of $40,000,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Erick Lucera acquired 3,000 shares of Valeritas Holdings stock in a transaction that occurred on Thursday, March 23rd. The shares were purchased at an average cost of $10.00 per share, for a total transaction of $30,000.00. Following the purchase, the chief financial officer now directly owns 3,000 shares of the company’s stock, valued at approximately $30,000. The disclosure for this purchase can be found here. Insiders have purchased 4,015,900 shares of company stock worth $40,101,615 in the last three months. Insiders own 1.20% of the company’s stock.
An institutional investor recently bought a new position in Valeritas Holdings stock. HighTower Advisors LLC acquired a new stake in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 27,400 shares of the company’s stock, valued at approximately $195,000. HighTower Advisors LLC owned 1.67% of Valeritas Holdings at the end of the most recent reporting period. Institutional investors and hedge funds own 11.65% of the company’s stock.
WARNING: “Valeritas Holdings, Inc. (VLRX) Expected to Post Quarterly Sales of $5.14 Million” was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://www.chaffeybreeze.com/2017/07/18/valeritas-holdings-inc-vlrx-expected-to-post-quarterly-sales-of-5-14-million-updated-updated-updated.html.
Valeritas Holdings (VLRX) traded down 16.80% on Thursday, reaching $5.15. 32,060 shares of the company’s stock were exchanged. The company’s market cap is $35.24 million. The firm has a 50 day moving average of $5.41 and a 200-day moving average of $21.22. Valeritas Holdings has a 12-month low of $4.51 and a 12-month high of $52.00.
Valeritas Holdings Company Profile
Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Valeritas Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.